Brief: Kintor Pharmaceutical Received Investigational New Drug Clearance By Us FDA For GT20029 In US
13/07/2021 16:14
July 13 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK :
* RECEIVED INVESTIGATIONAL NEW DRUG CLEARANCE BY US FDA FOR
GT20029 IN US
Further company coverage: 9939.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint